psoriasis

Partner Content

Photography by Sophie Harris Taylor (Swerve Represents Ltd)

Partner Content

Global ‘PsoriasIS NOT CONTAGIOUS’ campaign for World Psorias...

Fishawack Health launches global disease awareness campaign, supported by the community of Psoriasis Warriors to de-stigmatize psoriasis during the COVID-19 pandemic.

News

Popit and Almirall's new app tracks adherence to psoriasis m...

Finnish startup Popit has joined with Spain’s Almirall to produce an app that tracks whether patients have taken their psoriasis medicine and sends them a reminder if they miss a dose.

News

BMS' deucravacitinib psoriasis pill outperforms Amgen's Otez...

Bristol-Myers Squibb could be on the verge of a major coup in psoriasis after its deucravacitinib pill outperformed Amgen’s rival Otezla.

Views & Analysis

Holistic immunology: Supporting patients at every stage of t...

As part of our series from leaders at Janssen, the company’s Max Pahlow looks at how approaches

News

Phase 3 wins put Dermavant closer to filing Otezla rival tap...

Just two years after buying rights to psoriasis candidate tapinarof from GlaxoSmithKline, Swiss biotech Dermavant says it could be a few months away from filing for approval of

News

UCB’s IL-17 latecomer bimekizumab beats Cosentyx in psoriasi...

Belgian biopharma company UCB is bringing up the rear of the IL-17 inhibitor category with its bimekizumab drug, so is celebrating new late-stage data showing superiority to th

Global ‘PsoriasIS NOT CONTAGIOUS’ campaign for World Psorias...

Popit and Almirall's new app tracks adherence to psoriasis m...

BMS' deucravacitinib psoriasis pill outperforms Amgen's Otez...

Holistic immunology: Supporting patients at every stage of t...

Phase 3 wins put Dermavant closer to filing Otezla rival tap...

UCB’s IL-17 latecomer bimekizumab beats Cosentyx in psoriasi...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

psoriasis

Editor's Picks